BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Jenscare, with innovative TTVR, releases 2024H1 interim results

  August 28, 2024

   · 

  2 min read
• Press Releases

  Yunovia Announces IND Approval by the MFDS to Initiate Phase 1 MAD Study for the Small Molecule GLP-1 Agonist

  August 28, 2024

   · 

  3 min read
• Press Releases

  Novartis twice-yearly* Leqvio® demonstrated clinically meaningful, statistically significant LDL-C lowering as a monotherapy in patients at low or moderate ASCVD risk

  August 28, 2024

   · 

  10 min read
• Press Releases

  PCI Biotech first half 2024 interim results

  August 28, 2024

   · 

  3 min read
• Press Releases

  argenx to Present at Upcoming September 2024 Investor Conferences

  August 28, 2024

   · 

  1 min read
• Press Releases

  Hemogenyx Pharmaceuticals PLC Announces Presentation at CBD S&T Conference

  August 28, 2024

   · 

  2 min read
• Press Releases

  PulseSight Therapeutics Confirms H2 2024 Conference Schedule

  August 28, 2024

   · 

  3 min read
• Press Releases

  Medigene to Present at Upcoming September 2024 Investor Conferences

  August 28, 2024

   · 

  2 min read
• Press Releases

  Hyundai Bioscience to conduct phase 3 clinical trial for high-risk group of COVID-19 patients with the goal of emergency use authorization

  August 28, 2024

   · 

  4 min read
• Press Releases

  Compass Pathways to participate in three investor conferences in September 2024

  August 28, 2024

   · 

  3 min read